CRA Timor was founded on January 2006 by the senior partners of Coelho Ribeiro & Associados – CRA Portugal, a Portuguese Law Firm with a well-established practice with over 30 years of experience in the legal profession.
Since CRA Timor´s establishment in the territory onwards our mission and main purpose is to provide the best legal advice and solutions to foreign investors interested in doing business in the Democratic Republic of Timor-Leste as well as supporting national governmental and non-governmental bodies and international organizations.
CRA Timor was, has been and is committed to be the pioneer and leading international Law firm in Timor-Leste.
CRA Timor News
O Prémio Nobel da Paz José Ramos-Horta apelou hoje ao Governo timorense para que aprove um pacote de assistência às vítimas do ciclone Idai em Moçambiqueread more
Portugal fará com a Argentina em Timor-Leste a sua primeira Cooperação Triangular fora de África, disse hoje à agência Lusa a Secretária de Estado dos Negócios Estrangeiros e da Cooperação, Teresa Ribeiroread more
CRA Timor Newsletter
CRA Timor Newsletter
Jan., Feb., Mar., Apr. and May 2018
CRA Global Insights
Proposed EU regulation on free flow of non-personal data to impact on data storage and processing services (October 2017)
Mónica Oliveira Costa, on the October edition of Digital Health Legal journal, the proposal of the European Regulation on the free flow of non-personal data and its impact on digital health sectorread more
Felix Majani comments the new legal regime governing and regulating employment contract of the sports practitioner, sports training contract as well as representatives and agents approved by the Law 54/2017 that came into force July 19, 2017read more
The Constitutional Court takes position on mandatory arbitration in generic medicines disputes (August 2017)
João Sequeira Marcelino and Ana Carolina Santos comment the decision of the Constitutional Court of 24 of May of 2017 that establishes that a Defendant may oppose to the Claimant the nullity or invalidity of patents of generic medicines with mere inter partes effectsread more